Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where C. E. Swanson is active.

Publication


Featured researches published by C. E. Swanson.


BJUI | 2002

Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: A randomized controlled trial

Heather J. Green; Kenneth I. Pakenham; B. C. Headley; John Yaxley; David L. Nicol; P. Mactaggart; C. E. Swanson; R. B. Watson; Robert A. Gardiner

Objective  To report the first systematic investigation of the cognitive effects of luteinizing hormone‐releasing hormone (LHRH) analogues in male patients, as LHRH analogues have been associated with memory impairments in women using these drugs for gynaecological conditions.


BJUI | 2004

Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial.

Heather J. Green; Kenneth I. Pakenham; B. C. Headley; J. Yaxley; D. L. Nicol; P. Mactaggart; C. E. Swanson; R. B. Watson; Robert A. Gardiner

To investigate the effects of different management strategies for non‐localized prostate cancer on mens quality of life and cognitive functioning.


Kidney International | 2012

Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life

Wendy E. Hoy; Andrew White; Alison Dowling; Suresh Sharma; H. Bloomfield; Bernard Tipiloura; C. E. Swanson; John D. Mathews; David A. McCredie

Although unusual in western countries and in Australia in general, post-streptococcal glomerulonephritis (PSGN) is still common in Australian Aboriginal children living in remote communities. Here, we evaluated whether episodes of acute PSGN increased the risk for chronic kidney disease in later life in 1519 residents of a remote Aboriginal community (85% of those age eligible), with high rates of renal and cardiovascular disease, who participated in a health screen over a 3-year period. Of these, 200 had had at least one episode of PSGN, with 27 having had multiple episodes, usually in childhood. High levels of albuminuria (albumin/creatinine ratio) with increasing age were confirmed. All PSGN episodes were associated with group A streptococcal skin infections, often related to scabies. In both genders, aged 10-39 years at screening, about one in five had such a history. Among them, PSGN (5 years or more earlier) was significantly associated with higher levels of albuminuria than those without. In women, aged 30-39 years, a history of PSGN was associated with a significantly higher frequency of estimated glomerular filtration rates <60 ml/min. The adjusted odds ratios for an albumin/creatinine ratio over 34 g/mol (overt albuminuria) in males and females with a history of PSGN were 4.6 and 3.1, respectively, compared with those without a history. Thus, PSGN contributes to the very serious burden of chronic kidney disease in this community. Rigorous strategies to prevent scabies and Group A streptococcal infections will reduce this burden.


Foot & Ankle International | 2001

Operative treatment of ankle fractures: a minimum ten-year follow-up.

Gregory Day; C. E. Swanson; Bradley G. Hulcombe

The long-term outcome of 25 patients with bimalleolar fractures of the ankle was assessed ten to fourteen years following their fractures using the Phillips scoring system. All patients had undergone open reduction and anatomical internal fixation (as described in their operative notes in the medical records). 52% of patients had a good or excellent overall outcome while 24% had a poor overall outcome. This study has the longest follow-up period (10 to 14 years) to date on the outcomes of internal fixation of bimalleolar ankle fractures and demonstrates a higher percentage of poorer outcomes than has been previously described. This trend appears to be predictable as other studies with shorter term follow-up have already established a trend of increasing radiological evidence of post-traumatic arthritis with successively longer-term outcome reports.


General Hospital Psychiatry | 1995

Psychological responses to malignant melanoma: An investigation of traumatic stress rections to life-threatening illness

Brian Kelly; Beverley Raphael; Mark Smithers; C. E. Swanson; Carla Reid; Rod McLeod; D. Thomson; Ewan Walpole

A cross-sectional study of 95 individuals with malignant melanoma was conducted to investigate posttraumatic stress responses to a diagnosis of melanoma and to validate the use of the Impact of Event Scale (IES) as a measure of the response to the trauma of life-threatening disease. The diagnosis and progression of malignant disease are likely to present a range of acute and chronic trauma to the individual and the individuals family. The findings suggest that the IES is a reliable and valid measure of this distress, with scores varying according to disease progression and prognostic status of nonmetastatic disease patients. This indicates the importance of clinical attention to the specific symptoms that may best reflect the traumatic impact of life-threatening illness and its progression, and the applicability of posttraumatic stress syndromes in understanding the psychological distress of this clinical population.


The Lancet | 2001

Enteral human IgG for prevention of necrotising enterocolitis: a placebo-controlled, randomised trial

Gregor Lawrence; David Tudehope; Kathryn C. Baumann; Heather E. Jeffery; Andrew W. Gill; Michael J Cole; John Drew; Andrew J. McPhee; John Ratcliffe; Graham Reynolds; John Simes; C. E. Swanson; David Cartwright; Peter G Davis; Ian Humphrey; Andrew Berry

BACKGROUND Neonatal necrotising enterocolitis is a serious, commonly fatal disease in premature neonates. Although feeding with expressed breast milk and other good nursery practices are partly protective, preventive measures are needed. Treating neonates enterally with a mixture of human IgA and IgG, prepared from donated blood, has been claimed to protect against necrotising enterocolitis. However, no IgA preparation is available in Australia. Our aim, therefore, was to identify whether or not enteral IgG could prevent the disorder. METHODS We did a multicentre, double-blind, placebo- controlled trial. We randomly assigned 768 infants to receive human IgG 1200 mg/kg daily, and 761 to receive placebo, for up to 28 days. Treatment began at the same time as enteral feeding. The primary outcome measure was the proportion of infants who developed definite necrotising enterocolitis during the trial, and any deaths that resulted from the disorder in the treatment and placebo groups. Analysis was on an intention-to-treat basis. FINDINGS 43 infants developed definite necrotising enterocolitis in the IgG group, ten of whom died. In the placebo group, 41 infants contracted the disorder and six died (p=0.47). 25 infants on IgG and 36 on placebo had suspect necrotising enterocolitis (p=0.14). INTERPRETATION Supplementation of enteral feeds with human IgG does not reduce necrotising enterocolitis.


Journal of Rehabilitation Medicine | 2005

Outcome measurement in Australian rehabilitation environments

Heather Anne Douglas; C. E. Swanson; T. Gee; Nicholas Bellamy

OBJECTIVE To determine the frequency and pattern of methods of outcome assessment used in Australian physical rehabilitation environments. DESIGN Postal survey. METHODS A questionnaire on service type, staffing, numbers of adults treated and outcome measures used for 7 conditions related to injury and road trauma as well as stroke and neuromuscular disorders was sent to 973 services providing adult physical rehabilitation treatment. RESULTS Questionnaires were completed by 440 service providers for a response rate of 45%, similar to that reported in a recent European survey reported in this journal. A small number of measures were reported as in use by most respondents, while a large number of measures were used by a few respondents. Measures of physical changes were used more frequently than those of generic well-being or quality of life. Ease of use and reporting to other professionals were cited as the most important reasons in selection of outcome measures. CONCLUSION This Australian-wide survey detected considerable heterogeneity in outcome measurement procedures used in rehabilitation environments. While the goal of measurement may vary between providers and differ between conditions, the results highlight opportunities for harmonization, bench-marking and measurement of health-related quality of life.


Anz Journal of Surgery | 2001

Surgical outcomes of a randomized prospective trial involving patients with a proximal femoral fracture

Gregory Day; C. E. Swanson; C. Yelland; J. Broome; K. Dimitri; L. Massey; H. Richardson; A. Marsh

Background: An orthopaedic management/patient‐focused care unit (OMPFCU) involving a dedicated orthopaedic–geriatrics liaison team was established at the Royal Brisbane Hospital in 1994 in an effort to safely accelerate rehabilitation of patients with proximal femoral fractures.


Pathology International | 2001

Phyllodes tumors of the breast: Correlation of nucleolar organizer regions with histopathological malignancy grading, flow cytometric DNA analysis and clinical outcome

Hemamali Samaratunga; Belinda Clarke; Leigh Owen; Greg Bryson; C. E. Swanson

To examine whether nucleolar organizer regions detected by argyrophilia (Ag‐NOR counts) can be used as a prognostic indicator in phyllodes tumors of the breast, and to compare its usefulness with that of DNA flow cytometric analysis, 28 cases of breast phyllodes tumors (including 15 benign, two borderline and 11 malignant tumors) were subjected to Ag‐NOR staining and counting as well as DNA flow cytometric analysis. S‐phase fraction and DNA ploidy analysis showed useful trends for improving outcome predictions in malignant phyllodes tumors. However, high Ag‐NOR counts were significant in predicting survival status (P= 0.013) and reached near statistical significance in predicting survival times (P= 0.07). In predicting survival status, results for Ag‐NOR counts were significantly better than those for ploidy analysis (P= 0.02) and S‐phase fraction (P< 0.01). Only S‐phase fraction was significantly predictive of survival times (P= 0.025). It is concluded that Ag‐NOR counts and DNA flow cytometric analysis, easily performed using paraffin sections, give information that can improve predictions made by histopathological classification. Ag‐NOR counts are significant in predicting survival in the presence of histopathological features of malignancy.


BJUI | 2000

Inactive free : total prostate specific antigen ratios in ejaculate from men with suspected and known prostate cancer, compared with young control men

Judith A. Clements; T. Merritt; K. DeVoss; C. E. Swanson; L. Hamlyn; B. Scells; Peter P. Rohde; Martin F. Lavin; J. Yaxley; Robert A. Gardiner

Objective To measure free : total prostate specific antigen (PSA) ratios in ejaculate from men with suspected and known prostate cancer, and in young control men, to determine if this ratio might be useful in discriminating benign from malignant prostatic conditions.

Collaboration


Dive into the C. E. Swanson's collaboration.

Top Co-Authors

Avatar

Wendy E. Hoy

University of Queensland

View shared research outputs
Top Co-Authors

Avatar

H. Bloomfield

University of Queensland

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

S. Sharma

Charles Darwin University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

P. Mactaggart

Queen Elizabeth II Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gurmeet Singh

Charles Darwin University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge